Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer
Xin Wang,1,2 Feifei Teng,2 Jie Lu,3 Dianbin Mu,4 Jianbo Zhang,4 Jinming Yu1,21Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, People’s Republic of China; 2Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University...
Main Authors: | Wang X, Teng F, Lu J, Mu D, Zhang J, Yu J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/expression-and-prognostic-role-of-ikbke-and-tbk1-in-stage-i-non-small--peer-reviewed-article-CMAR |
Similar Items
-
Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma
by: Yang WJ, et al.
Published: (2018-03-01) -
IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway
by: Li Yi, et al.
Published: (2020-07-01) -
Advances in IKBKE as a potential target for cancer therapy
by: Min Yin, et al.
Published: (2020-01-01) -
CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway
by: Xin Wang, et al.
Published: (2021-09-01) -
A Novel Transcript Isoform of TBK1 Negatively Regulates Type I IFN Production by Promoting Proteasomal Degradation of TBK1 and Lysosomal Degradation of IRF3
by: Jie Zhang, et al.
Published: (2020-09-01)